Paradigm Biocapital Advisors LP Oyster Point Pharma, Inc. Transaction History

Paradigm Biocapital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.41 - $8.38 $1.39 Million - $2.64 Million	314,986 Added 23.62%	1,648,316 $9.26 Million
Q2 2022 Aug 15, 2022	BUY	$3.6 - $11.2 $1.24 Million - $3.87 Million	345,632 Added 34.99%	1,333,330 $5.77 Million
Q1 2022 May 16, 2022	BUY	$8.58 - $17.65 $5.86 Million - $12.1 Million	683,460 Added 224.65%	987,698 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $3.09 Million - $5.77 Million	304,238 New	304,238 $5.56 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.